Considerations for Venetoclax + Azacitidine Administration and AE Management
June 9th 2022
Richard Stone, MD, and Eunice Wang, MD, discuss considerations and challenges related to the administration of venetoclax and azacitidine in the community setting, and share strategies for managing adverse events associated with this combination.